POLAREAN Company Profile
✉ Email this page to a colleague
What is the competitive landscape for POLAREAN, and when can generic versions of POLAREAN drugs launch?
POLAREAN has one approved drug.
There are two US patents protecting POLAREAN drugs.
There are six patent family members on POLAREAN drugs in six countries.
Summary for POLAREAN
| International Patents: | 6 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for POLAREAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | 11,052,161 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | 10,583,205 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for POLAREAN Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 106456808 | ⤷ Sign Up |
| Hungary | E045999 | ⤷ Sign Up |
| European Patent Office | 3107583 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2015127208 | ⤷ Sign Up |
| Canada | 2940109 | ⤷ Sign Up |
| Australia | 2015218883 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
